Effectiveness of childhood vaccination against rotavirus in sub-Saharan Africa: The case of Nigeria

被引:5
作者
Melliez, H.
Boelle, P. Y.
Baron, S.
Mouton, Y.
Yazdanpanah, Y.
机构
[1] Serv Univ Reg Maladies Infect, Fac Med Lille, F-59208 Tourcoing, France
[2] INSERM, U707, Paris, France
[3] Dept Informat Med & Epidemiol, Lille, France
[4] Fac Med, EA 2694, Lille, France
[5] CNRS, URa 362, Lab Rech Econ, F-59019 Lille, France
关键词
rotavirus mortality; sub-Saharan Africa; rotavirus vaccine;
D O I
10.1016/j.vaccine.2006.07.038
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Rotavirus diarrhoea is associated with high childhood mortality in developing countries. A new vaccine was recently licensed in Mexico. The objective of this study was to assess the effectiveness of routine childhood vaccination by this new vaccine in a developing country. We constructed a decision tree to compare two alternatives: "no vaccination programme" and "vaccination programme". The estimates used for disease incidence, vaccine efficacy and coverage rates were derived from published data. We followed a hypothetical Nigerian cohort from birth to age five. The vaccine programme would prevent 284,000 cases of rotavirus diarrhoea annually and 6129 deaths due to the disease. In this study in a sub-Saharan country, we showed that rotavirus vaccination with a new vaccine substantially reduces the number of deaths from rotavirus diarrhoea and may be of great use in developing countries. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:298 / 305
页数:8
相关论文
共 36 条
  • [1] Molecular epidemiology of rotaviruses in Nigeria: Detection of unusual strains with G2P[6] and G8P[1] specificities
    Adah, MI
    Wade, A
    Taniguchi, K
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (11) : 3969 - 3975
  • [2] ORAL REHYDRATION OF CHILDREN WITH DIARRHEA IN NIGERIA - A 12-YEAR REVIEW OF IMPACT ON MORBIDITY AND MORTALITY FROM DIARRHEAL DISEASES AND DIARRHEAL TREATMENT PRACTICES
    BABANIYI, OA
    [J]. JOURNAL OF TROPICAL PEDIATRICS, 1991, 37 (02) : 57 - 63
  • [3] BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705
  • [4] EVALUATION OF RHESUS ROTAVIRUS MONOVALENT AND TETRAVALENT REASSORTANT VACCINES IN US CHILDREN
    BERNSTEIN, DI
    GLASS, RI
    RODGERS, G
    DAVIDSON, BL
    SACK, DA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (15): : 1191 - 1196
  • [5] Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries
    Bresee, JS
    Glass, RI
    Ivanoff, B
    Gentsch, JR
    [J]. VACCINE, 1999, 17 (18) : 2207 - 2222
  • [6] DAVIDSON GP, 1975, LANCET, V1, P242
  • [7] DEVOS A, 2004, PEDIATR INFECT DIS J, V23, pS179
  • [8] Factors contributing to severity of rotavirus infection
    Dupont, C
    [J]. ARCHIVES DE PEDIATRIE, 1999, 6 : 327S - 329S
  • [9] A PROSPECTIVE-STUDY OF ROTAVIRUS INFECTION IN INFANTS AND YOUNG-CHILDREN
    GURWITH, M
    WENMAN, W
    HINDE, D
    FELTHAM, S
    GREENBERG, H
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1981, 144 (03) : 218 - 224
  • [10] THE EPIDEMIOLOGY OF ACUTE DIARRHEA IN A RURAL-COMMUNITY IN IMO-STATE, NIGERIA
    HUTTLY, SRA
    BLUM, D
    KIRKWOOD, BR
    EMEH, RN
    FEACHEM, RG
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1987, 81 (05) : 865 - 870